USD10
SRPT Shares
About Sarepta TherapeuticsSarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
USD10
SRPT Shares
About Sarepta TherapeuticsSarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM GMT+0
MARKET CAP
$2.11B
OPEN PRICE
$19.93
LOW (1Y)
$10.42
HIGH (1Y)
$111.59
LOW (24H)
$19.81
HIGH (24H)
$20.35
VOLUME (24H)
$902.07K
81.57%
Price history
Time | Price | Change |
|---|---|---|
Today | $19.93 | |
1 Day | $19.80 | |
1 Week | $17.47 | |
1 Month | $16.45 |